Jane Street’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-41,295
Closed -$41.2K 6549
2022
Q4
$41.2K Buy
41,295
+25,553
+162% +$25.5K ﹤0.01% 4923
2022
Q3
$28K Buy
15,742
+2,541
+19% +$4.52K ﹤0.01% 5241
2022
Q2
$38K Buy
+13,201
New +$38K ﹤0.01% 4969
2022
Q1
Sell
-63,142
Closed -$294K 6421
2021
Q4
$294K Buy
63,142
+51,949
+464% +$242K ﹤0.01% 4031
2021
Q3
$95K Buy
+11,193
New +$95K ﹤0.01% 4724
2021
Q2
Sell
-46,940
Closed -$1.04M 5978
2021
Q1
$1.04M Buy
46,940
+22,562
+93% +$498K ﹤0.01% 2464
2020
Q4
$754K Buy
+24,378
New +$754K ﹤0.01% 2377